Word

MINDERA

Status

Dead

Status Code

602

Status Date

Thursday, February 10, 2022

Serial Number

90305558

Mark Type

3000

Filing Date

Sunday, November 8, 2020

Abandoned Date

Tuesday, February 1, 2022

Trademark Owner History

MiNDERA Corporation

Classifications

44 Medical services; Nucleic acid sequencing and analysis services for medical purposes; Genome sequencing and analysis services for medical purposes; Medical genetic analysis and reporting services for diagnostic, prognostic or treatment uses; Medical testing and analysis for diagnostic and treatment purposes; DNA, RNA, nucleic acid and genetic sequencing, screening, and analysis services for medical purposes; Clinical diagnostic and consultation services for medical purposes in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine

42 Scientific and medical research, namely, analysis of cells, proteins and nucleic acids; Software as a service (SaaS) services and platform as a service (PaaS) featuring computer software platforms using machine-learning algorithms for collecting, storing, analyzing, sharing, reporting, and processing data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostic research, clinical research, drug development, drug development research, drug efficacy research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Hosting an online network service that enables users to store, analyze and share data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Clinical diagnostic and consultation services for research purposes in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Computer services, namely, cloud hosting provider services and onsite provider services in the nature of technical support services, namely, installation, administration, and troubleshooting of problems for computer software for storing, analyzing and sharing information in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Providing an online network service that enables users to store, access, manage, analyze and share data for use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Database design and development; RNA analysis services for scientific research purposes involving the identification and treatment of disease; Medical research services

The mark consists of The word Mindera with a line forming a circle shape starting, but not touching, above the d going to the left and down and ending, but not touching, under the d.

Trademark Events

Feb 10, 2022

Abandonment Notice E-Mailed - Failure To Respond

Feb 10, 2022

Abandonment - Failure To Respond Or Late Response

Jul 30, 2021

Notification Of Non-Final Action E-Mailed

Jul 30, 2021

Non-Final Action E-Mailed

Jul 30, 2021

Non-Final Action Written

Jul 2, 2021

Teas/Email Correspondence Entered

Jul 1, 2021

Correspondence Received In Law Office

Jul 1, 2021

Teas Response To Office Action Received

Apr 21, 2021

Notification Of Non-Final Action E-Mailed

Apr 21, 2021

Non-Final Action E-Mailed

Apr 21, 2021

Non-Final Action Written

Apr 14, 2021

Assigned To Examiner

Jan 9, 2021

Notice Of Design Search Code E-Mailed

Jan 8, 2021

New Application Office Supplied Data Entered In Tram

Nov 11, 2020

New Application Entered In Tram